Comparison of Defibrillation Efficacy and Survival Associated With Right Versus Left Pectoral Placement for Implantable Defibrillators

American Journal of Cardiology

Volumn 100, Issue 2, 2007, Pages 243-246

  Gold, Michael R ^a   Shih, Hue Teh ^b   Herre, John ^c   Breiter, David ^d   Zhang, Yunlong ^d   Schwartz, Mark ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d Medtronic Cardiac Rhythm Management   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CAUSE OF DEATH; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; GENDER; HAZARD RATIO; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PECTORAL MUSCLE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT CONTRAINDICATION;

AGED; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PECTORALIS MUSCLES; PROSPECTIVE STUDIES;

EID: 34447281719     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.02.087     Document Type: Article

References (21)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
2. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., Hafley G., and Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
3. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., and Heo M. Improved survival with an implanted defibrillator in patients with coronary artery disease at risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
4. Moss A.J., Zareba W.J., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., and Andrews M.L. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
5. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
6. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., DeMarco T., Carson P., DiCarlo L., DeMets D., White W.G., DeVries D.W., and Feldman A.M. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
7. Gold M.R., and Shorofsky S.R. Transvenous defibrillation lead systems. J Cardiovasc Electrophysiol 7 (1996) 570-580
8. Gold M.R., Olsovsky M.R., Pelini M.A., Peters R.W., and Shorofsky S.R. A comparison of single and dual coil active pectoral defibrillation lead systems. J Am Coll Cardiol 31 (1998) 1391-1394
9. Bardy G.H., Johnson G., Poole J.E., Dolack G.L., Kudenchuck P.J., Kelso D., Mitchell R., Mehra R., and Hofer B. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 88 (1993) 543-547
10. Gold M.R., Foster A.H., and Shorofsky S.R. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol 78 (1996) 540-543
11. Haffajee C., Martin D., Bhandari A., Bardy G.H., DeSouza C., Kuehlkamp V., Church T., and Jewel Active Can Investigator. A Multicenter, randomized trial comparing an active can implantable defibrillator with a passive can system. PACE 20 (1997) 215-219
12. Gold M.R., Foster A.H., and Shorofsky S.R. Lead system optimization for transvenous defibrillation. Am J Cardiol 80 (1997) 1163-1167
13. Epstein A.E., Kay G.N., Plumb V.J., Voshage-Stahl L., Hull M.L., and The Endotak Investigators. Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. J Cardiovasc Electrophysiol 6 (1995) 979-986
14. Flaker G.C., Tummala R., Wilson J., and The World Wide Jewel Investigators. Comparison of right- and left-sided pectoral implantation parameters with the Jewel active can cardiodefibrillator. PACE 21 (1998) 447-451
15. Jensen S.M., Pietersen A., and Chen X. Implantation of active can implantable defibrillators in the right pectoral region. PACE 21 (1998) 476-477
16. Kirk M.M., Shorofsky S.R., and Gold M.R. Comparison of the effects of active left and right pectoral pulse generators on defibrillation efficacy. Am J Cardiol 88 (2001) 1308-1311
17. Mann D.E., Klein R., Higgins S.L., Freedman R.A., Hahn S.J., and Huang Z.Z. The low energy safety study (LESS): rationale, design, patient characteristic and device utilization. Am Heart J 143 (2002) 199-204
18. Gold M.R., Higgins S.L., Klein R.C., Gilliam F.R., Kopelman H., Hessen S., Payne J., Srickberger S.A., Breiter D.J., and Hahn S.J. The efficacy and temporal stability of reduced safety margins for ventricular defibrillation: Primary results from the low energy safety study (LESS). Circulation 105 (2002) 2043-2048
19. Calle E.E., and Terrell D.D. Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol 137 (1993) 235-241
20. Lerman B.B., DiMarco J.P., and Haines D.E. Current-based versus energy-based ventricular defibrillation: a prospective study. J Am Coll Cardiol 12 (1988) 1259-1264
21. Schisterman E.F., and Whitcomb B.W. Use of the Social Security Administration Death Master File for ascertainment of mortality status. Population Health Metrics 2 (2004) 2